社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Isabelkhoo
IP属地:未知
+关注
帖子 · 9
帖子 · 9
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
Isabelkhoo
Isabelkhoo
·
2021-03-05
Thanks for the warning
非常抱歉,此主贴已删除
看
1,193
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Isabelkhoo
Isabelkhoo
·
2021-03-03
Great
U.S. stocks open lower on Wednesday; Dow down 0.11%<blockquote>周三美股低开;道指下跌0.11%</blockquote>
(March 3) Wall Street's main indexes opened lower on Wednesday as disappointing private employment d
U.S. stocks open lower on Wednesday; Dow down 0.11%<blockquote>周三美股低开;道指下跌0.11%</blockquote>
看
1,261
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Isabelkhoo
Isabelkhoo
·
2021-03-03
Nani
Ocugen stock soars after partner Bharat Biotech COVID-19 vaccine candidate shows 81% efficacy<blockquote>合作伙伴Bharat Biotech COVID-19候选疫苗显示出81%的功效后,Ocugen股价飙升</blockquote>
(March 3) Shares of Histogenics soared 41.0%, after the biopharmaceutical company said its co-develo
Ocugen stock soars after partner Bharat Biotech COVID-19 vaccine candidate shows 81% efficacy<blockquote>合作伙伴Bharat Biotech COVID-19候选疫苗显示出81%的功效后,Ocugen股价飙升</blockquote>
看
2,067
回复
评论
点赞
2
编组 21备份 2
分享
举报
Isabelkhoo
Isabelkhoo
·
2021-03-02
Yo //
@Ohyeah996
:Lol
非常抱歉,此主贴已删除
看
1,445
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Isabelkhoo
Isabelkhoo
·
2021-03-02
Woah
非常抱歉,此主贴已删除
看
1,501
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Isabelkhoo
Isabelkhoo
·
2021-03-02
Nice
非常抱歉,此主贴已删除
看
1,351
回复
评论
点赞
2
编组 21备份 2
分享
举报
Isabelkhoo
Isabelkhoo
·
2021-02-26
Cool
非常抱歉,此主贴已删除
看
1,326
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Isabelkhoo
Isabelkhoo
·
2021-02-26
Cool
非常抱歉,此主贴已删除
看
1,352
回复
评论
点赞
3
编组 21备份 2
分享
举报
Isabelkhoo
Isabelkhoo
·
2021-02-26
Nice
非常抱歉,此主贴已删除
看
1,539
回复
评论
点赞
3
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3565691414064920","uuid":"3565691414064920","gmtCreate":1602597855342,"gmtModify":1614307051812,"name":"Isabelkhoo","pinyin":"isabelkhoo","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/d0d46d565377e3b9597297e9ba8dff8e","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":12,"tweetSize":9,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.02","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.05%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":367195217,"gmtCreate":1614917790739,"gmtModify":1703482958577,"author":{"id":"3565691414064920","authorId":"3565691414064920","name":"Isabelkhoo","avatar":"https://static.tigerbbs.com/d0d46d565377e3b9597297e9ba8dff8e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565691414064920","idStr":"3565691414064920"},"themes":[],"htmlText":"Thanks for the warning ","listText":"Thanks for the warning ","text":"Thanks for the warning","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/367195217","repostId":"1112359794","repostType":4,"isVote":1,"tweetType":1,"viewCount":1193,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":364009916,"gmtCreate":1614783339135,"gmtModify":1703481102112,"author":{"id":"3565691414064920","authorId":"3565691414064920","name":"Isabelkhoo","avatar":"https://static.tigerbbs.com/d0d46d565377e3b9597297e9ba8dff8e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565691414064920","idStr":"3565691414064920"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/364009916","repostId":"1130537334","repostType":4,"repost":{"id":"1130537334","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据,旨在帮助投资者理解世界,做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1614782065,"share":"https://www.laohu8.com/m/news/1130537334?lang=zh_CN&edition=full","pubTime":"2021-03-03 22:34","market":"us","language":"en","title":"U.S. stocks open lower on Wednesday; Dow down 0.11%<blockquote>周三美股低开;道指下跌0.11%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1130537334","media":"老虎资讯综合","summary":"(March 3) Wall Street's main indexes opened lower on Wednesday as disappointing private employment d","content":"<p>(March 3) Wall Street's main indexes opened lower on Wednesday as disappointing private employment data for February dampened enthusiasm over a quick economic rebound fueled by a swift rollout of COVID-19 vaccines.</p><p><blockquote>(3月3日)华尔街主要指数周三低开,因令人失望的2月份私人就业数据打击了人们对新冠疫苗迅速推出推动经济快速反弹的热情。</blockquote></p><p>The Dow fell 0.11%, the S&P 500 dropped 0.12%, and the Nasdaq Composite retreated 0.14%.</p><p><blockquote>道指下跌0.11%,标普500下跌0.12%,纳斯达克综合指数下跌0.14%。</blockquote></p><p><img src=\"https://static.tigerbbs.com/f98e844edb04216bd6ef160e1ddfc0f5\" tg-width=\"1242\" tg-height=\"569\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. stocks open lower on Wednesday; Dow down 0.11%<blockquote>周三美股低开;道指下跌0.11%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. stocks open lower on Wednesday; Dow down 0.11%<blockquote>周三美股低开;道指下跌0.11%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time smaller\">2021-03-03 22:34</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>(March 3) Wall Street's main indexes opened lower on Wednesday as disappointing private employment data for February dampened enthusiasm over a quick economic rebound fueled by a swift rollout of COVID-19 vaccines.</p><p><blockquote>(3月3日)华尔街主要指数周三低开,因令人失望的2月份私人就业数据打击了人们对新冠疫苗迅速推出推动经济快速反弹的热情。</blockquote></p><p>The Dow fell 0.11%, the S&P 500 dropped 0.12%, and the Nasdaq Composite retreated 0.14%.</p><p><blockquote>道指下跌0.11%,标普500下跌0.12%,纳斯达克综合指数下跌0.14%。</blockquote></p><p><img src=\"https://static.tigerbbs.com/f98e844edb04216bd6ef160e1ddfc0f5\" tg-width=\"1242\" tg-height=\"569\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index","SPY":"标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1130537334","content_text":"(March 3) Wall Street's main indexes opened lower on Wednesday as disappointing private employment data for February dampened enthusiasm over a quick economic rebound fueled by a swift rollout of COVID-19 vaccines.The Dow fell 0.11%, the S&P 500 dropped 0.12%, and the Nasdaq Composite retreated 0.14%.","news_type":1,"symbols_score_info":{"SPY":0.9,".IXIC":0.9,".DJI":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":1261,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":364000818,"gmtCreate":1614783314334,"gmtModify":1703481101242,"author":{"id":"3565691414064920","authorId":"3565691414064920","name":"Isabelkhoo","avatar":"https://static.tigerbbs.com/d0d46d565377e3b9597297e9ba8dff8e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565691414064920","idStr":"3565691414064920"},"themes":[],"htmlText":"Nani","listText":"Nani","text":"Nani","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/364000818","repostId":"1172714394","repostType":4,"repost":{"id":"1172714394","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据,旨在帮助投资者理解世界,做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1614783206,"share":"https://www.laohu8.com/m/news/1172714394?lang=zh_CN&edition=full","pubTime":"2021-03-03 22:53","market":"us","language":"en","title":"Ocugen stock soars after partner Bharat Biotech COVID-19 vaccine candidate shows 81% efficacy<blockquote>合作伙伴Bharat Biotech COVID-19候选疫苗显示出81%的功效后,Ocugen股价飙升</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1172714394","media":"老虎资讯综合","summary":"(March 3) Shares of Histogenics soared 41.0%, after the biopharmaceutical company said its co-develo","content":"<p>(March 3) Shares of <a href=\"https://laohu8.com/S/OCGN\">Histogenics</a> soared 41.0%, after the biopharmaceutical company said its co-development partner Bharat Biotech released an interim analysis of its Phase 3 trial of its COVID-19 vaccine candidate, COVAXIN, which demonstrated efficacy of 81%.</p><p><blockquote>(3月3日)<a href=\"https://laohu8.com/S/OCGN\">组织发生学</a>飙升41.0%,此前该生物制药公司表示,其共同开发合作伙伴Bharat Biotech发布了对其COVID-19候选疫苗科瓦克辛的3期试验的中期分析,该试验显示疗效为81%。</blockquote></p><p><img src=\"https://static.tigerbbs.com/89ef5f4dcb688419ea9c6f73c920ffb8\" tg-width=\"1068\" tg-height=\"517\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p>Bharat's Phase 3 trial in India enrolled 25,800 participants aged 18 to 91, and the first interim analysis is based on 43 cases. A review of the safety database showed severe, serious and medically attended adverse events occurred at low levels and balanced between vaccine and placebo groups.</p><p><blockquote>Bharat在印度的3期试验招募了25800名年龄在18至91岁的参与者,首次中期分析基于43例病例。对安全性数据库的审查显示,严重、严重和医疗护理的不良事件发生率较低,并且在疫苗组和安慰剂组之间保持平衡。</blockquote></p><p>\"These results, which in part suggest significant immunogenicity against the rapidly emerging UK variant, represent an additional step towards outlining the regulatory pathway for EUA and approval in the United States,\" said Ocugen Chief Executive Shankar Musunuri.</p><p><blockquote>Ocugen首席执行官Shankar Musunuri表示:“这些结果部分表明针对快速出现的英国变种具有显着的免疫原性,这代表着朝着概述EUA和美国批准的监管途径又迈出了一步。”</blockquote></p><p>\"COVAXIN, a whole virion based vaccine candidate, is designed to fill a significant unmet need in our national arsenal of vaccines against COVID-19.\" Ocugen's stock has skyrocketed 3,071.5% over the past three months, while the iShares Nasdaq Biotechnology ETF has tacked on 6.8% and the S&P 500 has gained 5.6%.</p><p><blockquote>“科瓦克辛是一种基于整个病毒体的候选疫苗,旨在满足我们国家针对COVID-19的疫苗库中尚未满足的重大需求。”Ocugen的股价在过去三个月内飙升了3,071.5%,而iShares纳斯达克生物技术ETF上涨了6.8%,标普500上涨了5.6%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen stock soars after partner Bharat Biotech COVID-19 vaccine candidate shows 81% efficacy<blockquote>合作伙伴Bharat Biotech COVID-19候选疫苗显示出81%的功效后,Ocugen股价飙升</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen stock soars after partner Bharat Biotech COVID-19 vaccine candidate shows 81% efficacy<blockquote>合作伙伴Bharat Biotech COVID-19候选疫苗显示出81%的功效后,Ocugen股价飙升</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time smaller\">2021-03-03 22:53</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>(March 3) Shares of <a href=\"https://laohu8.com/S/OCGN\">Histogenics</a> soared 41.0%, after the biopharmaceutical company said its co-development partner Bharat Biotech released an interim analysis of its Phase 3 trial of its COVID-19 vaccine candidate, COVAXIN, which demonstrated efficacy of 81%.</p><p><blockquote>(3月3日)<a href=\"https://laohu8.com/S/OCGN\">组织发生学</a>飙升41.0%,此前该生物制药公司表示,其共同开发合作伙伴Bharat Biotech发布了对其COVID-19候选疫苗科瓦克辛的3期试验的中期分析,该试验显示疗效为81%。</blockquote></p><p><img src=\"https://static.tigerbbs.com/89ef5f4dcb688419ea9c6f73c920ffb8\" tg-width=\"1068\" tg-height=\"517\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p>Bharat's Phase 3 trial in India enrolled 25,800 participants aged 18 to 91, and the first interim analysis is based on 43 cases. A review of the safety database showed severe, serious and medically attended adverse events occurred at low levels and balanced between vaccine and placebo groups.</p><p><blockquote>Bharat在印度的3期试验招募了25800名年龄在18至91岁的参与者,首次中期分析基于43例病例。对安全性数据库的审查显示,严重、严重和医疗护理的不良事件发生率较低,并且在疫苗组和安慰剂组之间保持平衡。</blockquote></p><p>\"These results, which in part suggest significant immunogenicity against the rapidly emerging UK variant, represent an additional step towards outlining the regulatory pathway for EUA and approval in the United States,\" said Ocugen Chief Executive Shankar Musunuri.</p><p><blockquote>Ocugen首席执行官Shankar Musunuri表示:“这些结果部分表明针对快速出现的英国变种具有显着的免疫原性,这代表着朝着概述EUA和美国批准的监管途径又迈出了一步。”</blockquote></p><p>\"COVAXIN, a whole virion based vaccine candidate, is designed to fill a significant unmet need in our national arsenal of vaccines against COVID-19.\" Ocugen's stock has skyrocketed 3,071.5% over the past three months, while the iShares Nasdaq Biotechnology ETF has tacked on 6.8% and the S&P 500 has gained 5.6%.</p><p><blockquote>“科瓦克辛是一种基于整个病毒体的候选疫苗,旨在满足我们国家针对COVID-19的疫苗库中尚未满足的重大需求。”Ocugen的股价在过去三个月内飙升了3,071.5%,而iShares纳斯达克生物技术ETF上涨了6.8%,标普500上涨了5.6%。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172714394","content_text":"(March 3) Shares of Histogenics soared 41.0%, after the biopharmaceutical company said its co-development partner Bharat Biotech released an interim analysis of its Phase 3 trial of its COVID-19 vaccine candidate, COVAXIN, which demonstrated efficacy of 81%.Bharat's Phase 3 trial in India enrolled 25,800 participants aged 18 to 91, and the first interim analysis is based on 43 cases. A review of the safety database showed severe, serious and medically attended adverse events occurred at low levels and balanced between vaccine and placebo groups.\"These results, which in part suggest significant immunogenicity against the rapidly emerging UK variant, represent an additional step towards outlining the regulatory pathway for EUA and approval in the United States,\" said Ocugen Chief Executive Shankar Musunuri.\"COVAXIN, a whole virion based vaccine candidate, is designed to fill a significant unmet need in our national arsenal of vaccines against COVID-19.\" Ocugen's stock has skyrocketed 3,071.5% over the past three months, while the iShares Nasdaq Biotechnology ETF has tacked on 6.8% and the S&P 500 has gained 5.6%.","news_type":1,"symbols_score_info":{"OCGN":0.9}},"isVote":1,"tweetType":1,"viewCount":2067,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":362607954,"gmtCreate":1614616550078,"gmtModify":1703479009232,"author":{"id":"3565691414064920","authorId":"3565691414064920","name":"Isabelkhoo","avatar":"https://static.tigerbbs.com/d0d46d565377e3b9597297e9ba8dff8e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565691414064920","idStr":"3565691414064920"},"themes":[],"htmlText":"Yo //<a href=\"https://laohu8.com/U/3575028425176723\">@Ohyeah996</a>:Lol","listText":"Yo //<a href=\"https://laohu8.com/U/3575028425176723\">@Ohyeah996</a>:Lol","text":"Yo //@Ohyeah996:Lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/362607954","repostId":"1117820997","repostType":4,"isVote":1,"tweetType":1,"viewCount":1445,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":362604682,"gmtCreate":1614616518846,"gmtModify":1703479008376,"author":{"id":"3565691414064920","authorId":"3565691414064920","name":"Isabelkhoo","avatar":"https://static.tigerbbs.com/d0d46d565377e3b9597297e9ba8dff8e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565691414064920","idStr":"3565691414064920"},"themes":[],"htmlText":"Woah","listText":"Woah","text":"Woah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/362604682","repostId":"1189063169","repostType":4,"isVote":1,"tweetType":1,"viewCount":1501,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":362605912,"gmtCreate":1614616370336,"gmtModify":1703479007009,"author":{"id":"3565691414064920","authorId":"3565691414064920","name":"Isabelkhoo","avatar":"https://static.tigerbbs.com/d0d46d565377e3b9597297e9ba8dff8e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565691414064920","idStr":"3565691414064920"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/362605912","repostId":"1189063169","repostType":4,"isVote":1,"tweetType":1,"viewCount":1351,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":368471952,"gmtCreate":1614350860376,"gmtModify":1703476774810,"author":{"id":"3565691414064920","authorId":"3565691414064920","name":"Isabelkhoo","avatar":"https://static.tigerbbs.com/d0d46d565377e3b9597297e9ba8dff8e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565691414064920","idStr":"3565691414064920"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/368471952","repostId":"1117820997","repostType":4,"isVote":1,"tweetType":1,"viewCount":1326,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":368922152,"gmtCreate":1614275104876,"gmtModify":1703475761247,"author":{"id":"3565691414064920","authorId":"3565691414064920","name":"Isabelkhoo","avatar":"https://static.tigerbbs.com/d0d46d565377e3b9597297e9ba8dff8e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565691414064920","idStr":"3565691414064920"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/368922152","repostId":"2114317810","repostType":4,"isVote":1,"tweetType":1,"viewCount":1352,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":368921858,"gmtCreate":1614274828574,"gmtModify":1703475756773,"author":{"id":"3565691414064920","authorId":"3565691414064920","name":"Isabelkhoo","avatar":"https://static.tigerbbs.com/d0d46d565377e3b9597297e9ba8dff8e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565691414064920","idStr":"3565691414064920"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/368921858","repostId":"2114317810","repostType":4,"isVote":1,"tweetType":1,"viewCount":1539,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}